Semin Respir Crit Care Med 2021; 42(01): 127-144
DOI: 10.1055/s-0040-1716493
Review Article

Management and Challenges of Severe Traumatic Brain Injury

Shayan Rakhit
1   Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee
2   Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
,
Mina F. Nordness
1   Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee
2   Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
,
Sarah R. Lombardo
2   Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
,
Madison Cook
1   Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee
3   Meharry Medical College, Nashville, Tennessee
,
Laney Smith
1   Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee
4   Washington and Lee University, Lexington, Virginia
,
Mayur B. Patel
1   Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee
2   Division of Trauma, Emergency General Surgery, and Surgical Critical Care, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
5   Department of Neurosurgery and Hearing and Speech Sciences, Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, Tennessee
6   Surgical Service, Nashville VA Medical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs, Nashville, Tennessee
7   Geriatric Research, Education, and Clinical Center Service, Nashville VA Medical Center, Tennessee Valley Healthcare System, US Department of Veterans Affairs, Nashville, Tennessee
› Author Affiliations

Abstract

Traumatic brain injury (TBI) is the leading cause of death and disability in trauma patients, and can be classified into mild, moderate, and severe by the Glasgow coma scale (GCS). Prehospital, initial emergency department, and subsequent intensive care unit (ICU) management of severe TBI should focus on avoiding secondary brain injury from hypotension and hypoxia, with appropriate reversal of anticoagulation and surgical evacuation of mass lesions as indicated. Utilizing principles based on the Monro–Kellie doctrine and cerebral perfusion pressure (CPP), a surrogate for cerebral blood flow (CBF) should be maintained by optimizing mean arterial pressure (MAP), through fluids and vasopressors, and/or decreasing intracranial pressure (ICP), through bedside maneuvers, sedation, hyperosmolar therapy, cerebrospinal fluid (CSF) drainage, and, in refractory cases, barbiturate coma or decompressive craniectomy (DC). While controversial, direct ICP monitoring, in conjunction with clinical examination and imaging as indicated, should help guide severe TBI therapy, although new modalities, such as brain tissue oxygen (PbtO2) monitoring, show great promise in providing strategies to optimize CBF. Optimization of the acute care of severe TBI should include recognition and treatment of paroxysmal sympathetic hyperactivity (PSH), early seizure prophylaxis, venous thromboembolism (VTE) prophylaxis, and nutrition optimization. Despite this, severe TBI remains a devastating injury and palliative care principles should be applied early. To better affect the challenging long-term outcomes of severe TBI, more and continued high quality research is required.



Publication History

Article published online:
11 September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Centers of Disease Control and Prevention. https://www.cdc.gov/injury/wisqars/LeadingCauses.html . Accessed August 18, 2020
  • 2 GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1736-1788
  • 3 Callcut RA, Kornblith LZ, Conroy AS. et al; Western Trauma Association Multicenter Study Group. The why and how our trauma patients die: a prospective multicenter Western trauma association study. J Trauma Acute Care Surg 2019; 86 (05) 864-870
  • 4 Gunst M, Ghaemmaghami V, Gruszecki A, Urban J, Frankel H, Shafi S. Changing epidemiology of trauma deaths leads to a bimodal distribution. Proc Bayl Univ Med Cent 2010; 23 (04) 349-354
  • 5 Centers of Disease Control and Prevention. Surveillance Report of Traumatic Brain Injury-related Emergency Department Visits, Hospitalizations, and Deaths. Accessed April 1, 2020 at: https://www.cdc.gov/traumaticbraininjury/pdf/TBI-Surveillance-Report-FINAL_508.pdf
  • 6 GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18 (01) 56-87
  • 7 Taylor CA, Bell JM, Breiding MJ, Xu L. Traumatic brain injury-related emergency department visits, hospitalizations, and deaths - United States, 2007 and 2013. MMWR Surveill Summ 2017; 66 (09) 1-16
  • 8 Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2 (7872): 81-84
  • 9 Rimel RW, Jane JA, Edlich RF. An injury severity scale for comprehensive management of central nervous system trauma. JACEP 1979; 8 (02) 64-67
  • 10 Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: the FOUR score. Ann Neurol 2005; 58 (04) 585-593
  • 11 Marshall LF, Marshall SB, Klauber MR. et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 1992; 9 (Suppl. 01) S287-S292
  • 12 Maas AI, Hukkelhoven CW, Marshall LF, Steyerberg EW. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery 2005; 57 (06) 1173-1182 , discussion 1173–1182
  • 13 Mikati AG, Flahive J, Khan MW. et al. Multicenter validation of the survival after acute civilian penetrating brain injuries (SPIN) Score. Neurosurgery 2019; 85 (05) E872-E879
  • 14 Werner C, Engelhard K. Pathophysiology of traumatic brain injury. Br J Anaesth 2007; 99 (01) 4-9
  • 15 Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology 2001; 56 (12) 1746-1748
  • 16 Chi JH, Knudson MM, Vassar MJ. et al. Prehospital hypoxia affects outcome in patients with traumatic brain injury: a prospective multicenter study. J Trauma 2006; 61 (05) 1134-1141
  • 17 Spaite DW, Hu C, Bobrow BJ. et al. Mortality and prehospital blood pressure in patients with major traumatic brain injury: implications for the hypotension threshold. JAMA Surg 2017; 152 (04) 360-368
  • 18 Chesnut RM, Marshall LF, Klauber MR. et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34 (02) 216-222
  • 19 McHugh GS, Engel DC, Butcher I. et al. Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT study. J Neurotrauma 2007; 24 (02) 287-293
  • 20 Miller JD, Sweet RC, Narayan R, Becker DP. Early insults to the injured brain. JAMA 1978; 240 (05) 439-442
  • 21 Fuller G, Hasler RM, Mealing N. et al. The association between admission systolic blood pressure and mortality in significant traumatic brain injury: a multi-centre cohort study. Injury 2014; 45 (03) 612-617
  • 22 Spaite DW, Bobrow BJ, Keim SM. et al. Association of statewide implementation of the prehospital traumatic brain injury treatment guidelines with patient survival following traumatic brain injury: the excellence in prehospital injury care (EPIC) study. JAMA Surg 2019; 154 (07) e191152
  • 23 Davis DP, Peay J, Sise MJ. et al. The impact of prehospital endotracheal intubation on outcome in moderate to severe traumatic brain injury. J Trauma 2005; 58 (05) 933-939
  • 24 Bernard SA, Nguyen V, Cameron P. et al. Prehospital rapid sequence intubation improves functional outcome for patients with severe traumatic brain injury: a randomized controlled trial. Ann Surg 2010; 252 (06) 959-965
  • 25 Bossers SM, Schwarte LA, Loer SA, Twisk JW, Boer C, Schober P. Experience in prehospital endotracheal intubation significantly influences mortality of patients with severe traumatic brain injury: a systematic review and meta-analysis. PLoS One 2015; 10 (10) e0141034
  • 26 Sperry J. Prehospital airway control trial (PACT). Accessed April 2, 2020 at: https://clinicaltrials.gov/ct2/show/NCT04100564
  • 27 Cooper DJ, Myles PS, McDermott FT. et al; HTS Study Investigators. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004; 291 (11) 1350-1357
  • 28 Bulger EM, May S, Brasel KJ. et al; ROC Investigators. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 2010; 304 (13) 1455-1464
  • 29 Henry S. ATLS 10th edition offers new insights into managing trauma patients. Accessed August 18, 2020 at: https://bulletin.facs.org/2018/06/atls-10th-edition-offers-new-insights-into-managing-trauma-patients/
  • 30 Li J, Murphy-Lavoie H, Bugas C, Martinez J, Preston C. Complications of emergency intubation with and without paralysis. Am J Emerg Med 1999; 17 (02) 141-143
  • 31 Zeiler FA, Teitelbaum J, West M, Gillman LM. The ketamine effect on ICP in traumatic brain injury. Neurocrit Care 2014; 21 (01) 163-173
  • 32 Baekgaard JS, Eskesen TG, Sillesen M, Rasmussen LS, Steinmetz J. Ketamine as a rapid sequence induction agent in the trauma population: a systematic review. Anesth Analg 2019; 128 (03) 504-510
  • 33 Roberts BW, Karagiannis P, Coletta M, Kilgannon JH, Chansky ME, Trzeciak S. Effects of PaCO2 derangements on clinical outcomes after cerebral injury: a systematic review. Resuscitation 2015; 91: 32-41
  • 34 Carney N, Totten AM, O'Reilly C. et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017; 80 (01) 6-15
  • 35 Holcomb JB, Tilley BC, Baraniuk S. et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313 (05) 471-482
  • 36 Sperry JL, Guyette FX, Brown JB. et al; PAMPer Study Group. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med 2018; 379 (04) 315-326
  • 37 Geddes AE, Burlew CC, Wagenaar AE. et al. Expanded screening criteria for blunt cerebrovascular injury: a bigger impact than anticipated. Am J Surg 2016; 212 (06) 1167-1174
  • 38 Bullock MR, Chesnut R, Ghajar J. et al; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute subdural hematomas. Neurosurgery 2006; 58 (3, suppl): S16-S24, discussionSi-iv
  • 39 Bullock MR, Chesnut R, Ghajar J. et al; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of acute epidural hematomas. Neurosurgery 2006; 58 (3, suppl): S7-S15, discussionSi-iv
  • 40 Bullock MR, Chesnut R, Ghajar J. et al; Surgical Management of Traumatic Brain Injury Author Group. Surgical management of traumatic parenchymal lesions. Neurosurgery 2006; 58 (3, suppl): S25-S46, discussionSi-iv
  • 41 Mendelow AD, Gregson BA, Rowan EN. et al; STITCH(Trauma) Investigators. Early surgery versus initial conservative treatment in patients with traumatic intracerebral hemorrhage (STITCH[trauma]): the first randomized trial. J Neurotrauma 2015; 32 (17) 1312-1323
  • 42 van Essen TA, den Boogert HF, Cnossen MC. et al; CENTER-TBI Investigators and Participants. Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study. Acta Neurochir (Wien) 2019; 161 (03) 435-449
  • 43 Seelig JM, Becker DP, Miller JD, Greenberg RP, Ward JD, Choi SC. Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours. N Engl J Med 1981; 304 (25) 1511-1518
  • 44 Wilberger Jr JE, Harris M, Diamond DL. Acute subdural hematoma: morbidity, mortality, and operative timing. J Neurosurg 1991; 74 (02) 212-218
  • 45 Bor-Seng-Shu E, Figueiredo EG, Amorim RL. et al. Decompressive craniectomy: a meta-analysis of influences on intracranial pressure and cerebral perfusion pressure in the treatment of traumatic brain injury. J Neurosurg 2012; 117 (03) 589-596
  • 46 Cooper DJ, Rosenfeld JV, Murray L. et al; DECRA Trial Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med 2011; 364 (16) 1493-1502
  • 47 Hutchinson PJ, Kolias AG, Timofeev IS. et al; RESCUEicp Trial Collaborators. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med 2016; 375 (12) 1119-1130
  • 48 Nwachuku EL, Puccio AM, Fetzick A. et al. Intermittent versus continuous cerebrospinal fluid drainage management in adult severe traumatic brain injury: assessment of intracranial pressure burden. Neurocrit Care 2014; 20 (01) 49-53
  • 49 Tuettenberg J, Czabanka M, Horn P. et al. Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure. J Neurosurg 2009; 110 (06) 1200-1208
  • 50 Liu H, Wang W, Cheng F. et al. External ventricular drains versus intraparenchymal intracranial pressure monitors in traumatic brain injury: a prospective observational study. World Neurosurg 2015; 83 (05) 794-800
  • 51 Volovici V, Huijben JA, Ercole A. et al. Ventricular drainage catheters versus intracranial parenchymal catheters for intracranial pressure monitoring-based management of traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 2019; 36 (07) 988-995
  • 52 Talving P, Karamanos E, Teixeira PG. et al. Intracranial pressure monitoring in severe head injury: compliance with Brain Trauma Foundation guidelines and effect on outcomes: a prospective study. J Neurosurg 2013; 119 (05) 1248-1254
  • 53 Farahvar A, Gerber LM, Chiu YL, Carney N, Härtl R, Ghajar J. Increased mortality in patients with severe traumatic brain injury treated without intracranial pressure monitoring. J Neurosurg 2012; 117 (04) 729-734
  • 54 Alali AS, Fowler RA, Mainprize TG. et al. Intracranial pressure monitoring in severe traumatic brain injury: results from the American College of Surgeons Trauma Quality Improvement Program. J Neurotrauma 2013; 30 (20) 1737-1746
  • 55 Chesnut RM, Temkin N, Carney N. et al; Global Neurotrauma Research Group. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med 2012; 367 (26) 2471-2481
  • 56 Martini RP, Deem S, Yanez ND. et al. Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg 2009; 111 (04) 644-649
  • 57 Nangunoori R, Maloney-Wilensky E, Stiefel M. et al. Brain tissue oxygen-based therapy and outcome after severe traumatic brain injury: a systematic literature review. Neurocrit Care 2012; 17 (01) 131-138
  • 58 Okonkwo DO, Shutter LA, Moore C. et al. Brain oxygen optimization in severe traumatic brain injury phase-ii: a phase ii randomized trial. Crit Care Med 2017; 45 (11) 1907-1914
  • 59 Barsan WG. Brain oxygen optimization in severe TBI, phase 3 (BOOST3). Accessed April 3, 2020 at: https://clinicaltrials.gov/ct2/show/NCT03754114
  • 60 Chesnut R, Aguilera S, Buki A. et al. A management algorithm for adult patients with both brain oxygen and intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med 2020; 46 (05) 919-929
  • 61 Ponce LL, Pillai S, Cruz J. et al. Position of probe determines prognostic information of brain tissue PO2 in severe traumatic brain injury. Neurosurgery 2012; 70 (06) 1492-1502 , discussion 1502–1503
  • 62 Robertson CS, Gopinath SP, Goodman JC, Contant CF, Valadka AB, Narayan RK. SjvO2 monitoring in head-injured patients. J Neurotrauma 1995; 12 (05) 891-896
  • 63 Carteron L, Bouzat P, Oddo M. Cerebral microdialysis monitoring to improve individualized neurointensive care therapy: an update of recent clinical data. Front Neurol 2017; 8: 601
  • 64 Budohoski KP, Reinhard M, Aries MJ. et al. Monitoring cerebral autoregulation after head injury. Which component of transcranial Doppler flow velocity is optimal?. Neurocrit Care 2012; 17 (02) 211-218
  • 65 Ziegler D, Cravens G, Poche G, Gandhi R, Tellez M. Use of transcranial Doppler in patients with severe traumatic brain injuries. J Neurotrauma 2017; 34 (01) 121-127
  • 66 Hawryluk GWJ, Aguilera S, Buki A. et al. A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC). Intensive Care Med 2019; 45 (12) 1783-1794
  • 67 Alarcon JD, Rubiano AM, Okonkwo DO. et al. Elevation of the head during intensive care management in people with severe traumatic brain injury. Cochrane Database Syst Rev 2017; 12: CD009986
  • 68 Ho AM, Fung KY, Joynt GM, Karmakar MK, Peng Z. Rigid cervical collar and intracranial pressure of patients with severe head injury. J Trauma 2002; 53 (06) 1185-1188
  • 69 Joseph DK, Dutton RP, Aarabi B, Scalea TM. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma 2004; 57 (04) 687-693 , discussion 693–695
  • 70 Kilpatrick MM, Lowry DW, Firlik AD, Yonas H, Marion DW. Hyperthermia in the neurosurgical intensive care unit. Neurosurgery 2000; 47 (04) 850-855 , discussion 855–856
  • 71 Devlin JW, Skrobik Y, Gelinas C. et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med 2018; 46 (09) e825-e873 855
  • 72 Nordness MF, Haddad D, Rakhit S, Patel MB. Delirium after primary neurological injury. In: Hughes CG, Pandharipande PP, Ely EW. eds. Delirium: Acute Brain Dysfunction in the Critically Ill. Cham: Springer; 2020: 103-112
  • 73 Asehnoune K, Mrozek S, Perrigault PF. et al; BI-VILI study group. A multi-faceted strategy to reduce ventilation-associated mortality in brain-injured patients. The BI-VILI project: a nationwide quality improvement project. Intensive Care Med 2017; 43 (07) 957-970
  • 74 Davis DP, Dunford JV, Ochs M, Park K, Hoyt DB. The use of quantitative end-tidal capnometry to avoid inadvertent severe hyperventilation in patients with head injury after paramedic rapid sequence intubation. J Trauma 2004; 56 (04) 808-814
  • 75 Sookplung P, Siriussawakul A, Malakouti A. et al. Vasopressor use and effect on blood pressure after severe adult traumatic brain injury. Neurocrit Care 2011; 15 (01) 46-54
  • 76 Robertson CS, Hannay HJ, Yamal JM. et al; Epo Severe TBI Trial Investigators. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 2014; 312 (01) 36-47
  • 77 Myburgh J, Cooper DJ, Finfer S. et al; SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357 (09) 874-884
  • 78 Semler MW, Self WH, Wanderer JP. et al; SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults. N Engl J Med 2018; 378 (09) 829-839
  • 79 Rosenthal G, Sanchez-Mejia RO, Phan N, Hemphill III JC, Martin C, Manley GT. Incorporating a parenchymal thermal diffusion cerebral blood flow probe in bedside assessment of cerebral autoregulation and vasoreactivity in patients with severe traumatic brain injury. J Neurosurg 2011; 114 (01) 62-70
  • 80 Oddo M, Crippa IA, Mehta S. et al. Optimizing sedation in patients with acute brain injury. Crit Care 2016; 20 (01) 128
  • 81 Kelly DF, Goodale DB, Williams J. et al. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg 1999; 90 (06) 1042-1052
  • 82 Ghori KA, Harmon DC, Elashaal A. et al. Effect of midazolam versus propofol sedation on markers of neurological injury and outcome after isolated severe head injury: a pilot study. Crit Care Resusc 2007; 9 (02) 166-171
  • 83 Pandharipande PP, Pun BT, Herr DL. et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298 (22) 2644-2653
  • 84 Pandharipande PP, Girard TD, Jackson JC. et al; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med 2013; 369 (14) 1306-1316
  • 85 Sanfilippo F, Santonocito C, Veenith T, Astuto M, Maybauer MO. The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review. Neurocrit Care 2015; 22 (02) 325-334
  • 86 Hsiang JK, Chesnut RM, Crisp CB, Klauber MR, Blunt BA, Marshall LF. Early, routine paralysis for intracranial pressure control in severe head injury: is it necessary?. Crit Care Med 1994; 22 (09) 1471-1476
  • 87 Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988; 69 (01) 15-23
  • 88 Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2012; 12: CD000033
  • 89 Winer JW, Rosenwasser RH, Jimenez F. Electroencephalographic activity and serum and cerebrospinal fluid pentobarbital levels in determining the therapeutic end point during barbiturate coma. Neurosurgery 1991; 29 (05) 739-741 , discussion 741–742
  • 90 Diringer MN. New trends in hyperosmolar therapy?. Curr Opin Crit Care 2013; 19 (02) 77-82
  • 91 Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, Härtl R. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. J Neurosurg 2015; 122 (01) 202-210
  • 92 Mangat HS, Wu X, Gerber LM. et al. Hypertonic saline is superior to mannitol for the combined effect on intracranial pressure and cerebral perfusion pressure burdens in patients with severe traumatic brain injury. Neurosurgery 2020; 86 (02) 221-230
  • 93 Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ. A systematic review of randomized controlled trials comparing hypertonic sodium solutions and mannitol for traumatic brain injury: implications for emergency department management. Ann Pharmacother 2016; 50 (04) 291-300
  • 94 Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003; 44 (s10): 11-17
  • 95 Zimmermann LL, Diaz-Arrastia R, Vespa PM. Seizures and the role of anticonvulsants after traumatic brain injury. Neurosurg Clin N Am 2016; 27 (04) 499-508
  • 96 Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990; 323 (08) 497-502
  • 97 Inaba K, Menaker J, Branco BC. et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg 2013; 74 (03) 766-771 , discussion 771–773
  • 98 Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010; 12 (02) 165-172
  • 99 Mina AA, Knipfer JF, Park DY, Bair HA, Howells GA, Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma 2002; 53 (04) 668-672
  • 100 Prexl O, Bruckbauer M, Voelckel W. et al. The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old. Scand J Trauma Resusc Emerg Med 2018; 26 (01) 20
  • 101 Witt DM, Nieuwlaat R, Clark NP. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv 2018; 2 (22) 3257-3291
  • 102 Pollack Jr CV, Reilly PA, van Ryn J. et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med 2017; 377 (05) 431-441
  • 103 Grottke O, Aisenberg J, Bernstein R. et al. Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation. Crit Care 2016; 20 (01) 115
  • 104 Connolly SJ, Crowther M, Eikelboom JW. et al; ANNEXA-4 Investigators. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 2019; 380 (14) 1326-1335
  • 105 Joseph B, Pandit V, Meyer D. et al. The significance of platelet count in traumatic brain injury patients on antiplatelet therapy. J Trauma Acute Care Surg 2014; 77 (03) 417-421
  • 106 Thorn S, Güting H, Mathes T, Schäfer N, Maegele M. The effect of platelet transfusion in patients with traumatic brain injury and concomitant antiplatelet use: a systematic review and meta-analysis. Transfusion 2019; 59 (11) 3536-3544
  • 107 Zhang J, Zhang F, Dong JF. Coagulopathy induced by traumatic brain injury: systemic manifestation of a localized injury. Blood 2018; 131 (18) 2001-2006
  • 108 Rao A, Lin A, Hilliard C. et al. The utility of thromboelastography for predicting the risk of progression of intracranial hemorrhage in traumatic brain injury patients. Neurosurgery 2017; 64 (CN_suppl_1): 182-187
  • 109 Karri J, Cardenas JC, Matijevic N. et al. Early fibrinolysis associated with hemorrhagic progression following traumatic brain injury. Shock 2017; 48 (06) 644-650
  • 110 CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 2019; 394 (10210): 1713-1723
  • 111 Hoffman H, Jalal MS, Chin LS. The risk factors, outcomes, and costs associated with venous thromboembolism after traumatic brain injury: a nationwide analysis. Brain Inj 2019; 33 (13-14): 1671-1678
  • 112 Skrifvars MB, Bailey M, Presneill J. et al; EPO-TBI investigators and the ANZICS Clinical Trials Group. Venous thromboembolic events in critically ill traumatic brain injury patients. Intensive Care Med 2017; 43 (03) 419-428
  • 113 Van Gent JM, Bandle J, Calvo RY. et al. Isolated traumatic brain injury and venous thromboembolism. J Trauma Acute Care Surg 2014; 77 (02) 238-242
  • 114 Margolick J, Dandurand C, Duncan K. et al. A systematic review of the risks and benefits of venous thromboembolism prophylaxis in traumatic brain injury. Can J Neurol Sci 2018; 45 (04) 432-444
  • 115 Strollo BP, Bennett GJ, Chopko MS, Guo WA. Timing of venous thromboembolism chemoprophylaxis after traumatic brain injury. J Crit Care 2018; 43: 75-80
  • 116 Brandi G, Schmidlin A, Klinzing S, Schüpbach R, Unseld S, Pagnamenta A. Delayed prophylaxis with unfractionated heparin increases the risk of venous thromboembolic events in patients with moderate to severe traumatic brain injury: a retrospective analysis. Anaesthesiol Intensive Ther 2020; 52 (01) 28-33
  • 117 Gunning AC, Maier RV, de Rooij D, Leenen LPH, Hietbrink F. Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment. Eur J Trauma Emerg Surg 2019
  • 118 Hachem LD, Mansouri A, Scales DC, Geerts W, Pirouzmand F. Anticoagulant prophylaxis against venous thromboembolism following severe traumatic brain injury: A prospective observational study and systematic review of the literature. Clin Neurol Neurosurg 2018; 175: 68-73
  • 119 Spano II PJ, Shaikh S, Boneva D, Hai S, McKenney M, Elkbuli A. Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: A systematic review. J Trauma Acute Care Surg 2020; 88 (03) 454-460
  • 120 Störmann P, Osinloye W, Freiman TM, Seifert V, Marzi I, Lustenberger T. Early chemical thromboprophylaxis does not increase the risk of intracranial hematoma progression in patients with isolated severe traumatic brain injury. World J Surg 2019; 43 (11) 2804-2811
  • 121 Sumislawski JJ, Kornblith LZ, Conroy AS, Callcut RA, Cohen MJ. Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?. J Trauma Acute Care Surg 2018; 85 (05) 907-914
  • 122 Benjamin E, Recinos G, Aiolfi A, Inaba K, Demetriades D. Pharmacological thromboembolic prophylaxis in traumatic brain injuries: low molecular weight heparin is superior to unfractionated heparin. Ann Surg 2017; 266 (03) 463-469
  • 123 Allen A, Grigorian A, Christian A. et al. Intracranial pressure monitors associated with increased venous thromboembolism in severe traumatic brain injury. Eur J Trauma Emerg Surg 2020
  • 124 Dengler BA, Mendez-Gomez P, Chavez A. et al. Safety of chemical DVT prophylaxis in severe traumatic brain injury with invasive monitoring devices. Neurocrit Care 2016; 25 (02) 215-223
  • 125 Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT. Consensus Working Group. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma 2014; 31 (17) 1515-1520
  • 126 Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol 2017; 16 (09) 721-729
  • 127 Perkes I, Baguley IJ, Nott MT, Menon DK. A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol 2010; 68 (02) 126-135
  • 128 Lv LQ, Hou LJ, Yu MK. et al. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma 2010; 27 (11) 1945-1950
  • 129 Lv LQ, Hou LJ, Yu MK. et al. Risk factors related to dysautonomia after severe traumatic brain injury. J Trauma 2011; 71 (03) 538-542
  • 130 Mirhoseini MF, Hosay MA, McPherson M, Patel MB. Paroxysmal sympathetic hyperactivity: diagnostic criteria, complications, and treatment after traumatic brain injury. Curr Phys Med Rehabil Rep 2018; 6 (01) 81-88
  • 131 Samuel S, Allison TA, Lee K, Choi HA. Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nurs 2016; 48 (02) 82-89
  • 132 Tang Q, Wu X, Weng W. et al. The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study. PeerJ 2017; 5: e2986
  • 133 Ahl R, Thelin EP, Sjölin G. et al. β-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study. Eur J Trauma Emerg Surg 2017; 43 (06) 783-789
  • 134 Alali AS, Mukherjee K, McCredie VA. et al. Beta-blockers and traumatic brain injury: a systematic review, meta-analysis, and eastern association for the surgery of trauma guideline. Ann Surg 2017; 266 (06) 952-961
  • 135 Arbabi S, Campion EM, Hemmila MR. et al. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma 2007; 62 (01) 56-61 , discussion 61–62
  • 136 Chen Z, Tang L, Xu X, Wei X, Wen L, Xie Q. Therapeutic effect of beta-blocker in patients with traumatic brain injury: a systematic review and meta-analysis. J Crit Care 2017; 41: 240-246
  • 137 Cotton BA, Snodgrass KB, Fleming SB. et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma 2007; 62 (01) 26-33 , discussion 33–35
  • 138 Inaba K, Teixeira PG, David JS. et al. Beta-blockers in isolated blunt head injury. J Am Coll Surg 2008; 206 (03) 432-438
  • 139 Ley EJ, Leonard SD, Barmparas G. et al. Beta blockers in critically ill patients with traumatic brain injury: results from a multi-center, prospective, observational AAST study. J Trauma Acute Care Surg 2017
  • 140 Riordan Jr WP, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris Jr JA. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma 2007; 63 (03) 503-510 , discussion 510–511
  • 141 Schroeppel TJ, Sharpe JP, Shahan CP. et al. Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial. Trauma Surg Acute Care Open 2019; 4 (01) e000307
  • 142 Patel MB, McKenna JW, Alvarez JM. et al. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials 2012; 13: 177
  • 143 Fuchs C, Wauschkuhn S, Scheer C. et al. Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth 2017; 119 (04) 616-625
  • 144 Ratilal BO, Costa J, Pappamikail L, Sampaio C. Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev 2015; (04) CD004884
  • 145 Hoffman H, Jalal MS, Chin LS. The incidence of meningitis in patients with traumatic brain injury undergoing external ventricular drain placement: a nationwide inpatient sample analysis. Neurocrit Care 2019; 30 (03) 666-674
  • 146 May AK, Fleming SB, Carpenter RO. et al. Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients. Surg Infect (Larchmt) 2006; 7 (05) 409-417
  • 147 Asehnoune K, Seguin P, Allary J. et al; Corti-TC Study Group. Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): a double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med 2014; 2 (09) 706-716
  • 148 Edwards P, Arango M, Balica L. et al; CRASH trial collaborators. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005; 365 (9475): 1957-1959
  • 149 Skolnick BE, Maas AI, Narayan RK. et al; SYNAPSE Trial Investigators. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med 2014; 371 (26) 2467-2476
  • 150 Wright DW, Yeatts SD, Silbergleit R. et al; NETT Investigators. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med 2014; 371 (26) 2457-2466
  • 151 Zafonte RD, Bagiella E, Ansel BM. et al. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: citicoline brain injury treatment trial (COBRIT). JAMA 2012; 308 (19) 1993-2000
  • 152 Nichol A, French C, Little L. et al; EPO-TBI Investigators, ANZICS Clinical Trials Group. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet 2015; 386 (10012): 2499-2506
  • 153 Cooper DJ, Nichol AD, Bailey M. et al; POLAR Trial Investigators and the ANZICS Clinical Trials Group. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA 2018; 320 (21) 2211-2220
  • 154 Taylor SJ, Fettes SB, Jewkes C, Nelson RJ. Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury. Crit Care Med 1999; 27 (11) 2525-2531
  • 155 Acosta-Escribano J, Fernández-Vivas M, Grau Carmona T. et al. Gastric versus transpyloric feeding in severe traumatic brain injury: a prospective, randomized trial. Intensive Care Med 2010; 36 (09) 1532-1539
  • 156 Bilotta F, Caramia R, Cernak I. et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 2008; 9 (02) 159-166
  • 157 Finfer S, Chittock DR, Su SY. et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360 (13) 1283-1297
  • 158 Liu B, Liu S, Yin A, Siddiqi J. Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematic review and meta-analysis of randomized controlled trials. Crit Care 2015; 19: 409
  • 159 Krag M, Marker S, Perner A. et al; SUP-ICU trial group. Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 2018; 379 (23) 2199-2208
  • 160 Creutzfeldt CJ, Engelberg RA, Healey L. et al. Palliative care needs in the neuro-ICU. Crit Care Med 2015; 43 (08) 1677-1684
  • 161 Kahveci K, Dinçer M, Doger C, Yaricı AK. Traumatic brain injury and palliative care: a retrospective analysis of 49 patients receiving palliative care during 2013-2016 in Turkey. Neural Regen Res 2017; 12 (01) 77-83
  • 162 Côte N, Turgeon AF, Lauzier F. et al. Factors associated with the withdrawal of life-sustaining therapies in patients with severe traumatic brain injury: a multicenter cohort study. Neurocrit Care 2013; 18 (01) 154-160
  • 163 Wilson JE, Shinall Jr MC, Leath TC. et al. Worse than death: survey of public perceptions of disability outcomes after hypothetical traumatic brain injury. Ann Surg 2020
  • 164 Brown AW, Moessner AM, Mandrekar J, Diehl NN, Leibson CL, Malec JF. A survey of very-long-term outcomes after traumatic brain injury among members of a population-based incident cohort. J Neurotrauma 2011; 28 (02) 167-176
  • 165 Maiden MJ, Cameron PA, Rosenfeld JV, Cooper DJ, McLellan S, Gabbe BJ. Long-term outcomes after severe traumatic brain injury in older adults. a registry-based cohort study. Am J Respir Crit Care Med 2020; 201 (02) 167-177
  • 166 Ruet A, Bayen E, Jourdan C. et al. A detailed overview of long-term outcomes in severe traumatic brain injury eight years post-injury. Front Neurol 2019; 10: 120
  • 167 Patel MB. Illuminating Neuropsychological dysfunction and Systemic Inflammatory mechanisms Gleaned after Hospitalization in Trauma-ICU Study (INSIGHT-ICU). Accessed April 3, 2020 at: https://clinicaltrials.gov/ct2/show/NCT03098459
  • 168 TRACK-TBI. Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI). Accessed April 3, 2020 at: https://clinicaltrials.gov/ct2/show/NCT02119182
  • 169 Maas A. Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI). Accessed April 3, 2020 at: https://clinicaltrials.gov/ct2/show/NCT02210221